Randomized Controlled Trial
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Mar 27, 2023; 15(3): 440-449
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.440
Table 1 Characteristics and tumor sizes of the patients in the two groups

EMR-dB (n = 25)
ESD (n = 25)
P value
Age47.04 ± 10.5842.92 ± 10.930.182
Sex (Male/Female)13/1215/100.569
Tumor size (mm)4.53 ± 1.025.140 ± 1.740.141
Location (distance from anus) (cm)7.96 ± 3.527.36 ± 2.830.509
Resected lesion size (cm)1.32 ± 0.521.58 ± 0.840.269
Table 2 Therapeutic outcomes of endoscopic resection in the two groups

EMR-dB (n = 25)
ESD (n = 25)
P value
Histological complete resection, n (%)25 (100)25 (100)> 0.99
En bloc resection, n (%)25 (100)25 (100)> 0.99
Resection time (min)6.28 ± 0.7514.30 ± 1.51< 0.001
Delayed bleeding perforation020.470
Perforation00> 0.99
Devices cost$ 494.04 ± $ 85.47$ 808.98 ± $ 143.67< 0.001
Histopathological classification > 0.99
NET G1, n (%)25 (100)25 (100)
NET G2 00
NET G300
NEC00
Recurrence follow-up00> 0.99